Traxoprodil Mesylate Hydrate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTraxoprodil Mesylate Hydrate
Drug Alias Name曲索罗地NectivCP-101606
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor subunit epsilon 2 antagonists
TargetsGlutamate [NMDA] receptor subunit epsilon 2
Therapy Area/IndicationsDepressive Disorder, MajorStrokeParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingaporePortugal +[8] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorStrokeParkinson Disease

Other Information

ATC CodeN/A
Related LinksKEGG